Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense.

• Main Authors: Shilpi Verma, Andrea Loewendorf, Qiao Wang, Bryan McDonald, Alec Redwood, Chris A Benedict
• Format: Article
• Language: English
• Published: Public Library of Science (PLoS) 2014-08-01
• Series: PLoS Pathogens
• Online Access: http://europepmc.org/articles/PMC4133390?pdf=render

TNF-related apoptosis inducing ligand (TRAIL) death receptors (DR) regulate apoptosis and inflammation, but their role in antiviral defense is poorly understood. Cytomegaloviruses (CMV) encode many immune-modulatory genes that shape host immunity, and they utilize multiple strategies to target the TNF-family cytokines. Here we show that the m166 open reading frame (orf) of mouse CMV (MCMV) is strictly required to inhibit expression of TRAIL-DR in infected cells. An MCMV mutant lacking m166 expression (m166stop) is severely compromised for replication in vivo, most notably in the liver, and depleting natural killer (NK) cells, or infecting TRAIL-DR-/- mice, restored MCMV-m166stop replication completely. These results highlight the critical importance for CMV to have evolved a strategy to inhibit TRAIL-DR signaling to thwart NK-mediated defenses.